Metraipolis › archive › dc_96d3d7971071
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program — Europe PMC PMID:32841307
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32841307
- DOI
- 10.1371/journal.pone.0237430
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-07T16:05:01.547Z
- SHA-256 of the archived text
5fc3aee2e47f65c10bf49cc66e58eb3503a927ce8a07d0a1b35150d6713b1d99- Stable URL of this page
https://metraipolis.com/documento/dc_96d3d7971071
How to cite
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program — Europe PMC PMID:32841307 — Europe PMC (en), https://europepmc.org/article/MED/32841307 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_96d3d7971071 (Metraipolis archive dc_96d3d7971071, sha256 5fc3aee2e47f65c10bf49cc66e58eb3503a927ce8a07d0a1b35150d6713b1d99)
BibTeX
@misc{dc96d3d7971071,
title = {Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program — Europe PMC PMID:32841307},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32841307},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_96d3d7971071; sha256 5fc3aee2e47f65c10bf49cc66e58eb3503a927ce8a07d0a1b35150d6713b1d99},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32841307. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background & aims: Given ongoing challenges in non-invasive non-alcoholic liver disease (NAFLD) diagnosis, we sought to validate an ALT-based NAFLD phenotype using measures readily available in electronic health records (EHRs) and population-based studies by leveraging the clinical and genetic data in the Million Veteran Program (MVP), a multi-ethnic mega-biobank of US Veterans. Methods: MVP participants with alanine aminotransferases (ALT) >40 units/L for men and >30 units/L for women without other causes of liver disease were compared to controls with normal ALT. Genetic variants spanning eight NAFLD risk or ALT-associated loci (LYPLAL1, GCKR, HSD17B13, TRIB1, PPP1R3B, ERLIN1, TM6SF2, PNPLA3) were tested for NAFLD associations with sensitivity analyses adjusting for metabolic risk factors and alcohol consumption. A manual EHR review assessed performance characteristics of the NAFLD phenotype with imaging and biopsy data as gold standards. Genetic associations with advanced fibrosis were explored using FIB4, NAFLD Fibrosis Score and platelet counts. Results: Among 322,259 MVP participants, 19% met non-invasive criteria for NAFLD. Trans-ethnic meta-analysis replicated associations with previously reported genetic variants in all but LYPLAL1 and GCKR loci (P<6x10-3), without attenuation when adjusted for metabolic risk factors and alcohol consumption. At the previously reported LYPLAL1 locus, the established genetic variant did not appear to be associated with NAFLD, however the regional association plot showed a significant association with NAFLD 279kb downstream. In the EHR validation, the ALT-based NAFLD phenotype yielded a positive predictive value 0.89 and 0.84 for liver biopsy and abdominal imaging, respectively (inter-rater reliability (Cohen's kappa = 0.98)). HSD17B13 and PNPLA3 loci were associated with advanced fibrosis. Conclusions: We validate a simple, non-invasive ALT-based NAFLD phenotype using EHR data by leveraging previously established NAFLD risk-associated genetic polymorphisms. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-08-25). Identificativi: PMID 32841307 · PMCID PMC7447043 · DOI 10.1371/journal.pone.0237430. Pagina: https://europepmc.org/article/MED/32841307 — https://doi.org/10.1371/journal.pone.0237430. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-07T16:01:39.084Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.